Animal Tilmicosin Injection 25%/30%

Tilmicosin Injection  is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. 100ml Tilmicosin Injection has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Grampositive organisms such as Corynebacterium spp. Tilmicosin Injection is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Crossresistance between tilmicosin and other macrolide antibiotics has been observed. Tilmicosin Injection is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.

Indications

Animals Tilmicosin Injection indicated for the control and treatment of respiratory infections associated 

with tilmicosin-susceptible microorganisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus 

pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and 

swine.

Dosage
For oral administration.
Calves     :    Twice daily, 1 ml per 20 kg body weight via (artificial) milk for 3 - 5 days.
Poultry     :    300 ml per 1000 litres of drinking water (75 ppm) for 3 days.
Swine     :    800 ml per 1000 litres of drinking water (200 ppm) for 5 days.
Withdrawal times
- For meat: 
Calves     :    42 days.
Broilers   :    12 days.
Turkeys  :    19 days.
Swine    :    14 days.

Warning
Keep out of reach of children.